Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma

Clinical trial NCT03788746 · COMPLETED

Trial details

NCT number: NCT03788746
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Urothelial Carcinoma

Start date: 2019-01-17
Primary completion: 2022-01-12
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.